Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis
2013
Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.
1995
Microbiota in health and diseases
2022 Standout
Optical coherence tomography angiography
2017 Standout
Sinusoidal Dilatation and Congestion in Liver Biopsy: Is It Always Due to Venous Outflow Impairment?
2004
The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research
2009 Standout
Medical therapy of ulcerative colitis
1993
The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role
2011 Standout
Ulcerative Colitis
2011 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
2016 Standout
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
2015
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis
2008
Lewis enzyme (α1–3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population
2003
Intestinal barrier dysfunction in inflammatory bowel diseases
2008
Vascular disorders of the liver # †
2008 Standout
How host defense is encoded in the mammalian genome
2010 StandoutNobel
The influence of normal microbial flora on the development of chronic mucosal inflammation
1997
Metronidazole
1997
Ulcerative colitis
2012 Standout
COPII-coated vesicles: flexible enough for large cargo?
2005 StandoutNobel
Retinitis pigmentosa
2006 Standout
Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells
2005
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Use of antibiotics in the treatment of inflammatory bowel disease
2006
Intestinal mucosal barrier function in health and disease
2009 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis
1992
Anderson’s disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities
2008
High selenium diet protects against TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon
2007
Ulcerative colitis
2020 Standout
Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2−/− mice
2009 StandoutNobel
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Effect of Colchicine on Lymphocyte and Monocyte Function and Its Relation to Fibroblast Proliferation in Primary Biliary Cirrhosis
1990
Retinopathy induced in mice by targeted disruption of the rhodopsin gene
1997 StandoutNobel
COPII and the regulation of protein sorting in mammals
2011 StandoutNobel
Treatable Forms of Retinitis Pigmentosa Associated with Systemic Neurological Disorders
2001
The Translation of Helicobacter pylori Basic Research to Patient Care
2006
Seroprevalence of Helicobacter pylori, Incidence of Gastric Cancer, and Peptic Ulcer-Associated Hospitalizations in a Canadian Indian Population
1999
Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
2006 Standout
RECENT DEVELOPMENTS IN THE EPIDEMIOLOGY OF HELICOBACTER PYLORI
2000
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Retinitis pigmentosa
1988
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Commonly Used Preparations for Colonoscopy: Efficacy, Tolerability and Safety – A Canadian Association of Gastroenterology Position Paper
2006
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Primary Biliary Cirrhosis
1987 Standout
A controlled trial of colchicine in primary biliary cirrhosis
1987
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Primary Biliary Cirrhosis
2011 Standout
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Minocycline: far beyond an antibiotic
2013 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Inflammatory Bowel Disease
2010 Standout
Quality indicators for colonoscopy
2014 Standout
Validation of a new scale for the assessment of bowel preparation quality
2004
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Retinitis pigmentosa. The Friedenwald Lecture.
1993
The Role of the Microsomal Triglygeride Transfer Protein in Abetalipoproteinemia
2000
Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response
2009 StandoutNobel
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
A Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
1993
Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components
2000
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of G Delpré being referenced
Cholesterol turnover and metabolism in two patients with abetalipoproteinemia.
1983
A Comparative Study of Metronidazole and Sulfasalazine in Active, Not Severe, Ulcerative Colitis
1987
Comparison of Two Bowel Preparations for Colonoscopy: Sodium Picosulphate With Magnesium Citrate Versus Sulphate-Free Polyethylene Glycol Lavage Solution
1998
A Comparison of Metronidazole and Sulfasalazine in the Maintenance of Remission in Patients with Ulcerative Colitis
1989
Hypernephroma with nonmetastatic liver dysfunction (Stauffer's syndrome) and hypercalcemia. Case report and review of the literature.
1979
Endoscopic Assessment in Abetalipoproteinemia (Bassen-Kornzweig-Syndrome)
1978
Ultrastructural abnormalities in endoscopically and histologically normal and involved colon in ulcerative colitis.
1989
Helicobacter pylori infection and blood groups.
1996
In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine.
1984
Abetalipoproteinemia (Bassen-Kornzweig syndrome)
1977
Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.
1982